NYSE - Nasdaq Real Time Price USD

Baxter International Inc. (BAX)

41.02 +0.62 (+1.53%)
At close: April 23 at 4:00 PM EDT
41.35 +0.33 (+0.80%)
After hours: April 23 at 7:58 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
14,813,000.00
14,813,000.00
14,506,000.00
12,146,000.00
11,673,000.00
Cost of Revenue
9,838,000.00
9,838,000.00
9,440,000.00
7,426,000.00
7,086,000.00
Gross Profit
4,975,000.00
4,975,000.00
5,066,000.00
4,720,000.00
4,587,000.00
Operating Expense
4,563,000.00
4,563,000.00
4,435,000.00
3,384,000.00
3,036,000.00
Operating Income
412,000.00
412,000.00
631,000.00
1,336,000.00
1,551,000.00
Net Non Operating Interest Income Expense
-442,000.00
-442,000.00
-395,000.00
-193,000.00
-134,000.00
Other Income Expense
-74,000.00
-74,000.00
-2,886,000.00
-27,000.00
-125,000.00
Pretax Income
-103,000.00
-103,000.00
-2,650,000.00
1,116,000.00
1,292,000.00
Tax Provision
-34,000.00
-34,000.00
4,000.00
83,000.00
182,000.00
Net Income Common Stockholders
2,656,000.00
2,656,000.00
-2,433,000.00
1,284,000.00
1,102,000.00
Diluted NI Available to Com Stockholders
2,656,000.00
2,656,000.00
-2,433,000.00
1,284,000.00
1,102,000.00
Basic EPS
5.13
5.25
-4.83
2.56
2.17
Diluted EPS
5.13
5.25
-4.83
2.53
2.13
Basic Average Shares
506,250.00
506,000.00
504,000.00
502,000.00
509,000.00
Diluted Average Shares
506,250.00
506,000.00
504,000.00
508,000.00
517,000.00
Total Operating Income as Reported
390,000.00
390,000.00
-2,243,000.00
1,350,000.00
1,616,000.00
Total Expenses
14,401,000.00
14,401,000.00
13,875,000.00
10,810,000.00
10,122,000.00
Net Income from Continuing & Discontinued Operation
2,656,000.00
2,656,000.00
-2,433,000.00
1,284,000.00
1,102,000.00
Normalized Income
-23,070.00
-23,070.00
-379,740.00
1,045,150.00
1,208,532.51
Interest Income
70,000.00
70,000.00
20,000.00
14,000.00
19,000.00
Interest Expense
512,000.00
512,000.00
415,000.00
207,000.00
153,000.00
Net Interest Income
-442,000.00
-442,000.00
-395,000.00
-193,000.00
-134,000.00
EBIT
409,000.00
409,000.00
-2,235,000.00
1,323,000.00
1,445,000.00
EBITDA
1,672,000.00
1,672,000.00
-855,000.00
2,190,000.00
2,268,000.00
Reconciled Cost of Revenue
9,838,000.00
9,838,000.00
9,440,000.00
7,426,000.00
7,086,000.00
Reconciled Depreciation
1,263,000.00
1,263,000.00
1,380,000.00
867,000.00
823,000.00
Net Income from Continuing Operation Net Minority Interest
-76,000.00
-76,000.00
-2,666,000.00
1,022,000.00
1,102,000.00
Total Unusual Items Excluding Goodwill
-79,000.00
-79,000.00
-2,894,000.00
-25,000.00
-124,000.00
Total Unusual Items
-79,000.00
-79,000.00
-2,894,000.00
-25,000.00
-124,000.00
Normalized EBITDA
1,751,000.00
1,751,000.00
2,039,000.00
2,215,000.00
2,392,000.00
Tax Rate for Calcs
0.00
0.00
0.00
0.00
0.00
Tax Effect of Unusual Items
-26,070.00
-26,070.00
-607,740.00
-1,850.00
-17,467.49
12/31/2020 - 10/27/1981

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

BDX Becton, Dickinson and Company
234.36
+0.21%
 
ALC Alcon Inc.
80.76
+0.19%
 
TFX Teleflex Incorporated
211.11
+1.85%
 
COO The Cooper Companies, Inc.
91.68
+1.82%
 
BLCO Bausch + Lomb Corporation
14.85
+1.43%
 
HOLX Hologic, Inc.
77.19
+1.27%
 
EMBC Embecta Corp.
10.88
+1.49%
 
XRAY DENTSPLY SIRONA Inc.
30.86
+1.61%
 
RMD ResMed Inc.
184.22
+2.15%
 
NVST Envista Holdings Corporation
20.22
+0.55%